Breaking coverage of stock indices, sector moves, and trading activity to keep investors informed on what's driving Wall Street each day.
A director at Arcutis Biotherapeutics sold $121,000 in stock — but she still holds 27,500-plus shares. Meanwhile, the ZORYVE franchise posted 65% revenue growth. Here's what the numbers actually tell…
Dean Porter
A Strait of Hormuz closure drained the U.S. SPR to a 1983 low and triggered a global reserve-building race worth up to 1 billion barrels. Here's what that means for…
Eugene Castillo
UPS is spending $48 million on 27 temperature-controlled facilities to chase the $39.1 billion biologics market. With shares at $105.83, a 17.12 P/E and a hefty 6.2% yield, here's what…
Eugene Castillo
Philip Morris International jumped 3.27% to $178.69 as investors weighed EU regulation against its smoke-free growth and 3.29% dividend. Here's what the numbers reveal about the bull and bear cases…
Douglas Turner
A Social Security benefit cut isn't guaranteed, but the program's main trust fund is on track to run short by late 2032 and could pay just 78% of promised benefits.…
Dean Porter